24/7 Market News Snapshot 23 October, 2025 – Qualigen Therapeutics, Inc. Common Stock (NASDAQ:QLGN)
DENVER, Colo., 23 October, 2025 (www.247marketnews.com) – (NASDAQ:QLGN) are discussed in this article.
Qualigen Therapeutics, Inc. (NASDAQ:QLGN) is experiencing a remarkable surge in its stock performance, with shares rising significantly from an opening price of $3.31 to $5.05, reflecting an impressive 50.75% increase. This dramatic price movement is underscored by substantial trading volume, reaching 2.04 million shares, which indicates heightened investor interest and confidence in the company’s future growth. As QLGN approaches important resistance levels, market observers are keenly watching its momentum, suggesting potential for further gains in the biotech sector.
In addition to its stock performance, Qualigen has announced a pivotal strategic partnership with BitGo, a premier provider of digital asset infrastructure. This collaboration is aimed at enhancing Qualigen’s treasury strategy through the accumulation of investments in a diversified basket of the ten leading cryptocurrencies. By integrating BitGo’s sophisticated treasury management solutions, Qualigen is set to benefit from deep liquidity and industry-leading security, critical for navigating today’s intricate financial landscape.
BitGo’s advanced custody solutions will ensure that Qualigen’s treasury assets are securely stored, compliant with regulatory standards, and readily accessible for investment opportunities. Jerry Wang, Co-CEO of Qualigen, emphasized the company’s commitment to innovation and sustainable financial strategies through this partnership. He stated, “By expanding our corporate treasury with digital assets through our collaboration with BitGo, we are reinforcing our commitment to pioneering sustainability in a rapidly evolving digital economy.”
Mike Belshe, CEO of BitGo, highlighted the significance of this $30 million multi-asset allocation, indicating a transformative shift in corporate perceptions regarding digital asset treasury strategies. As Qualigen embraces this innovative approach, it not only marks a financial milestone but also positions itself as a leader in integrating cutting-edge solutions within corporate treasury practices, reflecting the growing intersection of technology and finance.
Related news for (QLGN)
- Today’s Top Performers: MoBot’s Market Review 10/23/25 05:00 PM
- Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation
- MoBot alert highlights: NYSE: TOVX, NASDAQ: WGRX, NASDAQ: IMG, NASDAQ: QLGN, NASDAQ: RVPH (10/23/25 04:00 PM)
- Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI)
